Quality Life Even with Hemophilia
We recommend
Zlepšování péče o pacienty s hemofilií A: Kde jsme a kam míříme?
Pohlédneme-li na dosavadní časový snímek léčby hemofilie, je patrné, že k velkým pokrokům došlo především v posledním desetiletí. Ze současného výzkumu je však zřejmé, že v závěsu za nimi už čekají další. Aktualizovaná doporučení Světové hemofilické federace (WFH – World Federation of Hemophilia) dokonce obsahují změněnou definici profylaxe a také další novinky. Nejen na to upozornilo sympozium nazvané „Zlepšování péče při hemofilii A: Kde jsme a kam míříme?“, které bylo součástí odborného programu virtuálního kongresu EAHAD 2021.
New Treatment Options for Hemophilia Come with Discussions on Important Issues
The organizing committee of this year's virtual congress of the European Association for…
CASE STUDY: Surgical Procedure in an Adolescent Patient with Severe Hemophilia A on Emicizumab Prophylaxis
This case study is narrated by MUDr. Bohumír Blažek from the Clinic of Pediatric Medicine at LF OU and...
Articles on this topic
Emicizumab Changes the Lifestyle of Patients with Hemophilia A
At the World Federation of Hemophilia (WFH) meeting, data were presented regarding the impact…
Transition of Hemophilia A Patients with a History of Coagulation Factor Inhibitor to Emicizumab
During the World Federation of Hemophilia (WFH) conference, held virtually in June 2020,…
Major Orthopedic Procedures in Patients with Inhibitor Treated with Emicizumab
Italian authors presented the results of a study of a small series of hemophilia patients with…
Boy with Hemophilia A with Inhibitor − Case Study with Voting
Presented by: Assoc. Prof. MUDr. Jan Blatný, Ph.D., Department of Pediatric Hematology, University...
How trends in sports evolve among hemophiliacs and to what extent they are limited by their disease
Historically, physical activity was generally not recommended for hemophiliacs; however, with…
Does Emicizumab Change Routine Clinical Practice?
With the increasing number of patients with hemophilia A being treated with emicizumab, the…
1
2
Subscribe
Conferences news
Go to records
Most read on this topic
- Boy with Hemophilia A with Inhibitor − Case Study with Voting
- CASE STUDY: Surgical Procedure in an Adolescent Patient with Severe Hemophilia A on Emicizumab Prophylaxis
- Interactive Case Study of a Patient with Severe Hemophilia A - Experience from Slovenia
- Transition of Hemophilia A Patients with a History of Coagulation Factor Inhibitor to Emicizumab
- Gene Therapy for Hemophilia A: What is the Expression of Factor VIII Using the Adeno-Associated Viral Vector SPK-8011?
- Reflection of Progress in Hemophilia Treatment in Current WFH Recommendations
Journal on this topic
Related topic